Breast Cancer Clinical Trials in New York

Showing 461-480 of 838 trials

Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy

NCT02314156

This randomized trial studies transdermal or oral telapristone acetate in treating patients undergoing surgery to remove the breast (mastectomy). Telapristone acetate may help prevent breast cancer from forming in premenopausal women. Giving telapristone acetate transdermally may be safer and have fewer side effects than oral administration.

BRCA1 Mutation CarrierBRCA2 Mutation CarrierDuctal Breast Carcinoma In Situ+6 more

Northwestern University67 participantsStarted Oct 2015

West Hollywood, California, United States • Chicago, Illinois, United States • New York, New York, United States

COMPLETEDPhase 2< 1 mile

Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer

NCT02049957

This is a phase 1b/2 study of the safety and efficacy of sapanisertib (MLN0128) in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/human epidermal growth factor receptor 2 negative (ER+/HER2-) advanced or metastatic breast cancer who progressed on treatment with everolimus in combination with exemestane or fulvestrant.

Breast Cancer

Calithera Biosciences, Inc118 participantsStarted Feb 2014

Los Angeles, California, United States • San Francisco, California, United States • Santa Barbara, California, United States +37 more locations

Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy

Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer

Breast Cancer Trials in Other Cities

RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF

S1200: Acupuncture, Sham Acupuncture, or Wait List for Joint Symptoms Related to Aromatase Inhibitors in Pts W/Early-Stage Breast Cancer

Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer

A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer

Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability

A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab

Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients

Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer

A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer

Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors

Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment

A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat

Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer

Investigating Safety, Tolerability and Efficacy of AZD5363 When Combined With Paclitaxel in Breast Cancer Patients

A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)

A Study of ZN-c5 and Abemaciclib in Participants With Breast Cancer

Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03

Other Conditions in New York